The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia – Response to Rashidi et al.

Andrew Kenneth McGregorDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Correspondence[email protected]

Deborah MoultonDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Nick BownNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Gavin CuthbertNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

David BournNorthern Genetics Service, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

Susanna MathewDepartment of Hematology, City Hospitals Sunderland NHS Foundation Trust, Sunderland, UK;

Raymond DangDepartment of Hematology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK;

Phillip MounterDepartment of Hematology, North Tees and Hartlepool Hospitals NHS Foundation Trust, Stockton-on-Tees, UK

Gail JonesDepartment of Hematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK;

show all

References

Rashidi A, Wolach O El-Jawahri A, et al. The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia. Leukemia Lymphoma 2016. doi:10.3109/10428194.2016.1161188.
PubMed Web of Science ®Google Scholar
McGregor A, Moulton D Bown N, et al. Incidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study. Leukemia Lymphoma 2016. http://dx.doi.org/10.3109/10428194.2015.1108413.
Web of Science ®Google Scholar
Proctor SJ, Wilkinson J Jones G, et al. Evaluation of treatment outcome in 175 patients with Hodgkin lymphoma aged 60 years or over: the SHIELD study. Blood 2012;119:6005–6015.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia – Response to Rashidi et al.

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The effect of FLT3-ITD and NPM1 mutation on survival in intensively treated elderly patients with cytogenetically normal acute myeloid leukemia – Response to Rashidi et al.

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date